JPS6256843B2 - - Google Patents

Info

Publication number
JPS6256843B2
JPS6256843B2 JP54084681A JP8468179A JPS6256843B2 JP S6256843 B2 JPS6256843 B2 JP S6256843B2 JP 54084681 A JP54084681 A JP 54084681A JP 8468179 A JP8468179 A JP 8468179A JP S6256843 B2 JPS6256843 B2 JP S6256843B2
Authority
JP
Japan
Prior art keywords
acid
strain
lipopolysaccharide
mycobacterium tuberculosis
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54084681A
Other languages
English (en)
Japanese (ja)
Other versions
JPS568320A (en
Inventor
Chisato Maruyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP8468179A priority Critical patent/JPS568320A/ja
Priority to US06/147,127 priority patent/US4329452A/en
Priority to FR8012794A priority patent/FR2484258A1/fr
Priority to CH5128/80A priority patent/CH650799A5/de
Priority to CA355,290A priority patent/CA1132047A/en
Priority to SU802943651A priority patent/SU1232124A3/ru
Priority to IT23219/80A priority patent/IT1132168B/it
Priority to ES493061A priority patent/ES8105783A1/es
Publication of JPS568320A publication Critical patent/JPS568320A/ja
Priority to US06/293,999 priority patent/US4394502A/en
Publication of JPS6256843B2 publication Critical patent/JPS6256843B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP8468179A 1979-07-04 1979-07-04 Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent Granted JPS568320A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP8468179A JPS568320A (en) 1979-07-04 1979-07-04 Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent
US06/147,127 US4329452A (en) 1979-07-04 1980-05-06 Immunotherapeutic agent for tumors comprising lipopolysaccharide as an active component
FR8012794A FR2484258A1 (fr) 1979-07-04 1980-06-09 Agent immunotherapique pour tumeurs, avec du lipopolysaccharide comme composant actif, et procede de preparation de cet agent
SU802943651A SU1232124A3 (ru) 1979-07-04 1980-07-03 Способ получени липоарабиноманнана,обладающего противоопухолевой активностью
CA355,290A CA1132047A (en) 1979-07-04 1980-07-03 Immunotherapeutic agent for tumors comprising lipopolysaccharide as an active component
CH5128/80A CH650799A5 (de) 1979-07-04 1980-07-03 Verfahren zur herstellung von lipopolysacchariden mit antitumoraktivitaet und immunotherapeutische mittel gegen tumore.
IT23219/80A IT1132168B (it) 1979-07-04 1980-07-03 Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo
ES493061A ES8105783A1 (es) 1979-07-04 1980-07-03 Un procedimiento para preparar un lipopolisacarido
US06/293,999 US4394502A (en) 1979-07-04 1981-08-18 Immunotherapeutic agent for tumors comprising lipopolysaccharide as an active component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8468179A JPS568320A (en) 1979-07-04 1979-07-04 Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent

Publications (2)

Publication Number Publication Date
JPS568320A JPS568320A (en) 1981-01-28
JPS6256843B2 true JPS6256843B2 (cg-RX-API-DMAC7.html) 1987-11-27

Family

ID=13837428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8468179A Granted JPS568320A (en) 1979-07-04 1979-07-04 Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent

Country Status (8)

Country Link
US (2) US4329452A (cg-RX-API-DMAC7.html)
JP (1) JPS568320A (cg-RX-API-DMAC7.html)
CA (1) CA1132047A (cg-RX-API-DMAC7.html)
CH (1) CH650799A5 (cg-RX-API-DMAC7.html)
ES (1) ES8105783A1 (cg-RX-API-DMAC7.html)
FR (1) FR2484258A1 (cg-RX-API-DMAC7.html)
IT (1) IT1132168B (cg-RX-API-DMAC7.html)
SU (1) SU1232124A3 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5718619A (en) * 1980-07-10 1982-01-30 Chisato Maruyama Tumor immunotherapy agent containing lipopolysaccharide as active principle
JPS59161320A (ja) * 1983-03-04 1984-09-12 Maruyama Chisato リポ多糖体およびその製造法
US4612304A (en) * 1985-06-11 1986-09-16 Ss Pharmaceutical Co., Ltd. Antitumor formulation containing lipopolysaccharide with trehalose derivatives
US4818751A (en) * 1985-07-02 1989-04-04 Zeria Shinyaku Kogyo Kabushiki Kaisha Cosmetics
EP0295749A1 (en) * 1987-06-15 1988-12-21 Duphar International Research B.V Sulpholipopolysaccharides as stimulators of the non-specific defence mechanism
US4798369A (en) * 1987-11-03 1989-01-17 The Firestone Tire & Rubber Company Ultrasonic air spring system
US7063844B2 (en) 1992-12-10 2006-06-20 The Brigham And Women's Hospital, Inc. Presentation of hydrophobic antigens to T-cells by CD1 molecules
US5853737A (en) * 1992-12-10 1998-12-29 Brigham And Women's Hospital Method for inducing a CD1-restricted immune response
US6238676B1 (en) * 1992-12-10 2001-05-29 Brigham And Women's Hospital Presentation of hydrophobic antigens to T-cells by CD1 molecules
US5712123A (en) * 1994-10-07 1998-01-27 Board Of Trustees Of The University Of Illinois Mixture having antitumor activities
CA2293821C (en) * 1997-06-10 2004-05-11 Tai Ho Chung Carbohydrate complex extracted from mycobacterium tuberculosis and process for the preparation thereof
US5869645A (en) * 1997-10-15 1999-02-09 Board Of Trustees Of The University Of Illinois Method for isolating high molecular weight antineoplastic glycans using urea
NZ505538A (en) * 2000-07-03 2004-12-24 Malaghan Inst Of Medical Res A vaccine comprising immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide (PIM); and the use of PIM for inducing an immune response in a patient effective in the prevention or treatment of Th2-mediated diseases or disorders such as asthma
US8034359B2 (en) 2004-06-07 2011-10-11 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to cancers
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
DK1765391T3 (da) * 2004-06-07 2013-03-25 Qu Biolog Inc Bakterielle præparater til behandlingen af cancer
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20070161546A1 (en) * 2005-12-15 2007-07-12 Colm King Methods and compositions for treatment of cancer
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
JP2015157763A (ja) * 2012-05-28 2015-09-03 エヌエーアイ株式会社 認知症の治療剤及び予防剤
WO2015153470A1 (en) 2014-03-31 2015-10-08 University Of Utah Research Foundation Fluid analysis device and associated systems and methods
CN113855791B (zh) 2014-05-02 2024-11-19 Qu生物制药公司 抗微生物免疫调节
WO2022075458A1 (ja) * 2020-10-09 2022-04-14 ゼリア新薬工業株式会社 結核菌抽出物の新規用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
FR2227862A1 (en) * 1973-05-04 1974-11-29 Anvar Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
NL7308450A (cg-RX-API-DMAC7.html) * 1972-06-20 1973-12-27
DE2527636A1 (de) * 1974-06-20 1976-01-08 Anvar Verfahren zur herstellung von mycobakteriellen fraktionen

Also Published As

Publication number Publication date
US4394502A (en) 1983-07-19
CA1132047A (en) 1982-09-21
FR2484258B1 (cg-RX-API-DMAC7.html) 1984-11-30
JPS568320A (en) 1981-01-28
ES493061A0 (es) 1981-06-16
CH650799A5 (de) 1985-08-15
IT1132168B (it) 1986-06-25
ES8105783A1 (es) 1981-06-16
SU1232124A3 (ru) 1986-05-15
FR2484258A1 (fr) 1981-12-18
US4329452A (en) 1982-05-11
IT8023219A0 (it) 1980-07-03

Similar Documents

Publication Publication Date Title
JPS6256843B2 (cg-RX-API-DMAC7.html)
JP3717511B2 (ja) サポニン−抗原複合物とその用途
JPH04503363A (ja) 新規リピドａ誘導体およびその用途
Azuma et al. Fractionation of mycobacterial cell wall. Isolation of arabinose mycolate and arabinogalactan from cell wall fraction of Mycobacterium tuberculosis strain Aoyama B
Paulsen et al. Structural studies of the polysaccharide from Aloe plicatilis Miller
DMIITRIEV et al. Somatic Antigens of Pseudomonas aeruginosa: The Structure of the Polysaccharide Chain of Ps. aeruginosa O‐Serogroup 7 (Lanyi) Lipopolysaccharide
JPS6399091A (ja) Ｏ−α−グリコシドおよびその製法
Sugita et al. Studies on glycosphingolipids of larvae of the green-bottle fly, Lucilia caesar I. Isolation and characterization of glycosphingolipids having novel sugar sequences
CN118126210B (zh) 一种菜豆种子均一多糖及其制备方法和应用
AU4883100A (en) Galactopyranosides and their use
Etzler et al. Immunochemical studies on blood groups: XLVI. Oligosaccharides isolated after hydrolysis of hog gastric mucin blood group A+ H substance previously treated with the blood group de-N-acetylating enzyme
Zdebska et al. Studies on the Structure and I‐Blood‐Group Activity of Poly (glycosyl) ceramides
Flowers Substituted cerebrosides: Part II. Synthetic dihydrosulfatides
US4767845A (en) Synthesis of tumor antigenic determinant
CN118791643A (zh) 桔梗均一多糖及其制备方法和应用
Halkes et al. Synthesis of the spacer-containing β-D-GalpNAc-(1→ 4)-β-D-GlcpNAc-(1→ 3)-α-D-Galp moiety, representing the non-fucosylated backbone trisaccharide of the glycocalyx glycan of the parasite Schistosoma mansoni
Gorshkova et al. Structural studies of O-specific polysaccharide chains of the lipopolysaccharide from Yersinia enterocolitica serovar O: 10
Lahmann et al. Synthesis of the Lewis b hexasaccharide and HSA-conjugates thereof
US4794176A (en) Synthesis of tumor antigenic determinant
JPH06510746A (ja) 免疫抑制性および寛容原性修飾ルイスｘおよびルイスａ化合物
Bhakoo et al. Isolation and characterization of a novel monoacylated glucopyranosyl neutral lipid from the plasma membrane of Acholeplasma laidlawii B
Jagtap et al. Extraction, structural characterization, and bioactivity of laminarin and fucoidan from brown macroalgae Chorda filum
JPH0565517B2 (cg-RX-API-DMAC7.html)
Vermelho et al. Isolation and Characterization of a Neutral Glycosphingolipid from the Epimastigote Form of Trypanosoma mega 1
JP2631686B2 (ja) 新規ステロイドサポニンおよびその製造法ならびにこれらの誘導体の新規用途